Abstract
Cerebral ischemia causes severe cell death or injury including axon breakdown or retraction in the brain. Axon regeneration is crucial for the functional recovery of injured neurons or brains after ischemia/reperfusion (I/R); however, this process has been proved extremely difficult in adult brains and there is still no effective therapy for it. Here we reported that neuroglobin (Ngb), a novel oxygen-binding or sensor protein existing predominantly in neurons or brains, functions as a driving factor for axon regeneration during I/R. Ngb was upregulated and accumulated in growth cones of ischemic neurons in primary cultures, rat, and human brains, correlating positively to the elevation of axon-regeneration markers GAP43, neurofilament-200, and Tau-1. Ngb overexpression promoted while Ngb knockdown suppressed axon regeneration as well as GAP43 expression in neurons during oxygen-glucose deprivation/reoxygenation (OGD/Re). By using specific pharmacological inhibitors, we identified p38 MAPK as the major downstream player of Ngb-induced axon regeneration during OGD/Re. Mechanistically, Ngb directly bound to and activated p38 in neurons upon OGD/Re. Serial truncation and point mutation of Ngb revealed that the 7–105 aa fragment of Ngb was required and the oxygen-binding site (His64) of Ngb was the major regulatory site for its p38 interaction/activation. Finally, administration of exogenous TAT-Ngb peptides significantly enhanced axon regeneration in cultured neurons upon OGD/Re. Taken together, Ngb promotes axon regeneration via O2-Ngb-p38-GAP43 signaling during I/R. This novel mechanism suggests potential therapeutic applications of Ngb for ischemic stroke and other related axonopathy.
Similar content being viewed by others
Introduction
Ischemic stroke is the most common disease causing disability in the elderly. Neurite or axon damage includes retraction/breakdown that usually occurs ahead of neuronal death due to energy depletion or brain edema, severely interrupting normal cell–cell interactions or neural circuits in the ischemic brain1. Axon regrowth/regeneration of injured neurons is indispensable for reconstruction of corrupted neurite communication/networks and is vital for the recovery of brain functions after ischemic stroke2,3. Therapeutic strategies such as cell transplantation and neuritogenesis-inducing reagents remain clinically ineffective, proving that neuritogenesis, particularly axonal regeneration, is extremely difficult in the adult brain4.
After ischemia, brain cells undergo three major pathological processes, i.e., cell injury/death, cell recovery/axon regeneration, and glial proliferation/scar formation2,5,6,7. Neurite or axon regeneration of injured neurons may launch soon after ischemic reperfusion (I/R), determined by the balance of driving/permissive signals (e.g., nerve growth factor), inhibitory/repulsive signals (e.g., Nogo), and glial scar formation that becomes increasingly severe along with I/R time1,2,4. Earlier initiation of axon regeneration during I/R that is driven predominantly by neuritogenesis-promoting signals is critical for the success of re-establishment of damaged neurite networks, for axon regrowth cues might exist in situ while glial barrier remains minor1,2,8. Current known neuritogenesis-promoting factors in the brain contain mainly neurotrophin families as well as their downstream signaling pathways (e.g., phosphoinositide-3 kinase (PI3K)/Akt and mitogen-activated protein kinases (MAPKs))8,9,10, which are identified from the developing brains and functions well mainly in the normal developing neurons8,10. Previous studies of axon regeneration under pathological conditions focus largely on mechanically injured neurons in the spinal cord or peripheral nerve tissues11,12, which differs from ischemic neurons in the brain. It is obvious that identifying novel endogenous axon regeneration-promoting factors in the ischemic brains is required for future development of effective axon regeneration drugs.
Neuroglobin (Ngb) is a novel hexa-coordinated heme-containing globin expressed predominantly in the mammalian brains13. As a native neuronal oxygen-binding protein, Ngb has been largely focused on its effect on neuronal or brain protection after ischemia. Most previous studies have reported a protective role of Ngb after ischemic injury or oxidative stress in stroke, spinal cord injury, and Alzheimer’s diseases14,15,16,17. However, damaging effects of Ngb in the ischemic brain has also been reported in Ngb-knockout mice18. Ngb binds not only with oxygen but also many signaling proteins such as Gαi, 14-3-3, Raf-1, PTEN, and Akt, suggesting that Ngb not only can sense oxygen/hypoxia signal but also is a direct linker of oxygen signal and intracellular signaling pathways19,20,21,22,23. Until now, the exact physiological/pathological function of Ngb in the brain has remained elusive.
In the present study, we found that the expression and distribution of Ngb in ischemic neurons were highly associated with axonal regeneration. We demonstrated that Ngb promoted axon regeneration during I/R via binding to and activating p38 depending on oxygen signal. Further, the therapeutic effect of Ngb peptides on axon regeneration was verified in cultured neurons.
Results
Ngb upregulation and accumulation correlate to axon regeneration in the mouse and human brains after ischemic stroke
To investigate the role of Ngb in axon regeneration after I/R, we first analyzed the relationship between Ngb and neuritogenesis markers in ipsilateral ischemic penumbra (Ipsi, indicated by the square box, Fig. 1a) in the I/R brains. Western blots showed that axon growth marker growth associated protein-43 (GAP43) was initially decreased within 24 h of reperfusion after 1 h of transient middle cerebral artery occlusion (tMCAo) and then upregulated at I/R-2, −3 and −7 days (Fig. 1b), reflecting a continuum of axon injury-regeneration process after I/R. Prominent Ngb upregulation appeared at I/R-2 days (Fig. 1b), correlating to early GAP43 induction after I/R. GSE4105 data analysis verified that Ngb mRNA was upregulated in the rat cortex after I/R-2 days (supplementary Figure S3). Double-fluorescent immunostaining showed that Ngb was co-localized to NeuN (indicated by arrowheads, Fig. 1c) but not to glial fibrillary acidic protein (GFAP) in the mouse I/R brain (Fig. 1c). Immunohistochemistry (IHC) results confirmed Ngb elevation in ischemic neurons in the I/R brains (Fig. 1d and supplementary Figure S4). Notably, Ngb was accumulated in neurite/growth cone of Ipsi ischemic neurons at I/R-2 days (indicated by arrows, Fig. 1d). Further, double-fluorescent immunostaining showed that Ngb was well co-localized to neuritogenesis marker neurofilament-200 (NF200; indicated by arrows, r = 0.9101, P < 0.0001, Fig. 1e) in ischemic neurons at I/R-2 days. In addition, Ngb was prominently elevated and accumulated in neurites or neuronal growth cones in the ischemic human brains (indicated by arrowheads, Fig. 1f). GSE16561 database analysis revealed that both Ngb and GAP43 were upregulated in the blood of patients after stroke (supplementary Figure S5). Such evidence together supported that endogenous Ngb was highly associated with axon regeneration in the brain after I/R.
Ngb promotes axon regeneration in the neuron during ischemic reperfusion
The positive correlation of Ngb expression and subcellular localization with axon regeneration in the ischemic brain was further verified in primary cultured cortical neurons. Western blots demonstrated that Ngb but not its homolog cytoglobin (Cygb) was significantly upregulated in the neurons upon OGD-1 h/Re-6, 12, and 24 h, correlating to the time course of GAP43 upregulation after OGD/Re (Fig. 2a). Double-fluorescent immunostaining showed that Ngb expression was positively correlated to axon growth markers Tau-1 (r = 0.9136, P < 0.0001) and GAP43 (r = 0.8181, P < 0.0001) in individual neurons upon OGD-1 h/Re-24 h (Fig. 2b). In addition, Ngb was highly accumulated in growth cones of OGD/Re-treated but not normal neurons (indicated by arrows, Fig. 2b).
The causative relationships between Ngb and axon regeneration in the neurons after ischemia were investigated by Ngb overexpression and knockdown. Morphological results showed that Ngb (Venus-Ngb) overexpression increased axon length (the longest neurite) in normal cultured cortical neurons and OGD/Re-treated neurons (indicated by arrows, Fig. 2c). Statistical analysis demonstrated that the relative mean length of axons was significantly increased in Ngb-overexpressing neurons upon OGD-1 h/Re-24 h (lower panel, Fig. 2c). Consistently, knockdown of endogenous Ngb by overexpressing pGensil-1-shNgb18,20 prominently reduced axon length in normal cultured neurons as well as in OGD/Re-treated neurons (Fig. 2d). Western blots revealed that Ngb overexpression significantly upregulated GAP43 and Tau-1 in the neurons (Fig. 2e), while Ngb knockdown significantly downregulated GAP43 and Tau-1 in the neurons upon OGD-1 h/Re-24 h (Fig. 2f). Taken together, we demonstrated that Ngb is an axon-regeneration-inducing factor after ischemic reperfusion.
p38 MAPK is a major downstream player of Ngb-induced axon regeneration during ischemic reperfusion
To search for downstream signaling pathway of Ngb-induced axon regeneration, we tested the effects of various kinase inhibitors on axon regeneration in OGD/Re-treated neurons upon Ngb overexpression. Representative micrographs showed that Ngb overexpression increased axon length upon OGD-1 h/Re-24 h (dimethyl sulfoxide, Fig. 3a). As a result, only SB203580, a specific inhibitor for p38 MAPK (supplementary Figure 6a), evidently prevented Ngb-induced axon or neurite regeneration in the neurons (indicated by red square, Fig. 3a) or N2a cells (supplementary Figure 6b) upon OGD/Re. Statistical analysis demonstrated that SB203580 but no other kinase inhibitors (e.g., KT5720, LY294002, GO6983, SB415286, PD98059, U0126) significantly reduced the mean length of axon of Ngb-overexpressing neurons compared to their corresponding Vec controls (Fig. 3a), implying that p38 was a major downstream target of Ngb-induced axon regeneration in neurons after I/R. Western blots showed that Ngb overexpression prominently increased p-p38 in the neurons after OGD-1 h/Re-12 and 24 h (Fig. 3b). In the mouse brains, p-p38 in accordance with Ngb was also significantly upregulated after I/R-12, 24 and 48 h (Fig. 3c). Consistently, double-fluorescent immunostaining revealed that the increase of p-p38 was positively correlated to that of Ngb in individual neurons upon OGD-1 h/Re-24 h (r = 0.7932, P < 0.0001, Fig. 3d). In the mouse brain subjected to I/R-24 h, p-p38 was also elevated and well co-localized to Ngb in the ischemic neurons (indicated by arrows, r = 0.8216, P < 0.0001, Fig. 3e). Further, overexpression of a kinase-dead p38 (p38 KD, i.e., p38K53A)24 completely abolished Ngb-facilitated neurite regeneration in N2a cells upon OGD-1 h/Re-24 h (Fig. 3f), verifying the role of p38 as a downstream target of Ngb in neurite regeneration. Such evidence together demonstrated that p38 MAPK is the major downstream pathway involving in Ngb-induced axon regeneration during ischemic reperfusion.
Ngb directly binds to and activates p38 via Ngb 7–122 aa fragment
Since Ngb could bind to signaling proteins and regulated their functions20,21,22,23, we further examined the interaction between Ngb and p38. Similar to cultured neurons, Ngb but not Cygb was selectively upregulated (supplementary Figure S7a), and they promoted neurite regrowth (supplementary Figure S7b and S7c) in neuroblastoma N2a cells after OGD/Re. Co-expression of NV-p38 and CV-Ngb (upper panels, Fig. 4a) or NV-Ngb + CV-p38 (lower panels, Fig. 4a) reconstituted Venus fluorescent signal in living N2a cells, which indicated a direct Ngb-p38 binding in neuronal cells. Upon OGD-1 h/Re-6 h, reconstituted Venus signals from NV-p38+CV-Ngb or NV-Ngb+CV-p38 pairs became much stronger compared to their corresponding normoxic controls (0 h) (Fig. 4a), suggesting that Ngb–p38 interactions were increased by OGD/Re treatment. Statistical analysis demonstrated that relative Venus fluorescent intensities were significantly increased in N2a cells upon OGD/Re incubation (Fig. 4b).
In order to dissect Ngb domain for its p38 interaction, we made a series of Ngb1–151 truncates by deleting 1–6 (Δ1–6), 1–18 (Δ1–18), 1–35 (Δ1–35), 1–42 (Δ1–42) aa from its N-terminal or 128–151 (Δ128–151), 123–151 (Δ123–151), 106–151 (Δ106–151) aa from its C-terminal based on its α-helix structure (Fig. 4c). Glutathione S-transferase (GST) pull-down assays revealed that Ngb bound to p38 in N2a cells upon OGD-1 h/Re-24 h (Fig. 4d). Deletion of Ngb 1–6, 123–151, or 128–151 aa did not affect its binding with p38 (Fig. 4d). However, further deletion of Ngb from either N-terminal (i.e., Δ1–18/1–35/1–42) or C-terminal (i.e., Δ106–151) prominently reduced its p38 binding upon OGD/Re (Fig. 4d). Deletion of Ngb 1–18 but not 1–6 aa abolished Ngb-induced p38 activation in N2a cells upon OGD-1 h/Re-24 h (Fig. 4e). Further, pharmacological inhibition of p38 MAPK by SB203580 significantly reduced Ngb-induced neurite regrowth in N2a cells upon OGD-1 h/Re-24 h (Fig. 4f). Such evidence together suggested that Ngb7–122 fragment was required for p38 binding/activation and axon regrowth during I/R.
Ngb promotes axon regeneration via linking reoxygenation signal to p38 MAPK
The facts that hypoxia plays an important regulatory role in axon development and that Ngb functions mainly under hypoxic/ischemic cellular contexts21,25,26 strongly suggest that Ngb may control axon regeneration via sensing hypoxia/oxygen signal. In the embryonic brains, Ngb was highly expressed and accumulated in growth cone/neurite in the cerebral cortex, suggesting a physiological role of Ngb in axon development in hypoxic embryos (supplementary Figure S8). Ngb knockdown (shNgb) in N2a cells significantly reduced neurite length after 3, 6, and 12 h of hypoxic (1% O2) incubation (Fig. 5a), while Ngb overexpression prominently increased neurite length in N2a cells upon hypoxia (Fig. 5b), indicating that Ngb-induced neurite outgrowth was associated with its O2-binding ability upon hypoxia. Indeed, GST pull down proved that increasing O2-binding affinity of Ngb by mutating its oxygen-binding site His64 to lysine (i.e., NgbH64L)27 evidently enhanced its p38 bindings in N2a cells under normoxia and OGD-1 h/Re-24 h while reducing Ngb’s Gαi-binding affinity (i.e., NgbE53Q and NgbE118Q) did not affect its p38 binding compared to other Ngb mutants (Fig. 5c). Consistently, reducing Ngb’s oxygen-binding affinity by H64A mutation abolished Ngb-induced p38 activation in the neurons upon OGD-1 h/Re-24 h (Fig. 5d). Such evidence supported that oxygen was a major regulatory element for Ngb–p38 binding. Finally, overexpressing NgbH64L significantly increased axon length in cultured neurons upon OGD-1 h/Re-24 h while p38 MAPK inhibition SB203580 completely suppressed NgbH64L-enhanced axonal regrowth (Fig. 5e). Therefore, both Ngb–p38 interactions and Ngb-induced axon regeneration were controlled by reoxygenation signal after I/R.
Exogenous administration of transmembrane Ngb peptides boosts axon regeneration upon ischemic reperfusion
As a brain-residual globin with higher affinity to oxygen than hemoglobin13,19, Ngb has great advantages to cope with hypoxia and sense oxygen signal after I/R25,26,28. It was interesting to test whether exogenous administration of transmembrane Ngb peptide could achieve therapeutic effect of axon regeneration in ischemic neurons or not. A TAT sequence was fused to Ngb (i.e., TAT-His-Ngb) in order to facilitate its ability in penetrating cell membrane. After 1 h of OGD incubation, equal amounts of purified TAT-His-Ngb or His-Ngb peptides (40 nM) was supplemented to culture media immediately after reoxygenation incubation. Fluorescent immunostaining of His-tag demonstrated that TAT-His-Ngb but not His-Ngb could enter into N2a cells (Fig. 6a) and neurons (Fig. 6b). Cell morphology clearly showed that N2a cell (Fig. 6a) or neuron (Fig. 6b) containing TAT-His-Ngb had much longer neurite or axon (indicated by arrows, Fig. 6a, b) compared to His-Ngb controls upon OGD-1 h/Re-24 h. Statistical analysis demonstrated that relative neurite length of N2a cells (lower panel, Fig. 6a) or axon length of neurons (lower panel, Fig. 6b) was significantly increased with TAT-His-Ngb treatment compared to His-Ngb or untreated (Non) controls upon OGD/Re. Double-fluorescent immunostaining showed that both Ngb and GAP43 were accumulated and co-localized well in TAT-His-Ngb-treated neurons upon OGD-1 h/Re-24 h (indicated by arrows, Fig. 6c). Consistently, western blots demonstrated that TAT-His-Ngb significantly increased GAP43 and p-p38 expression in cultured neurons upon OGD-1 h/Re-24 h (Fig. 6d). Pharmacological inhibition of p38 MAPK pathway by SB203580 suppressed TAT-His-Ngb-induced GAP43 expression in cultured neurons upon OGD/Re (Fig. 6d). These data supported therapeutic applications of TAT-His-Ngb in patients with stroke.
Discussion
In the present study, we demonstrated that Ngb, a member of hemoglobin families, was upregulated and accumulated in the growth cone of ischemia-injured neuron. Ngb promoted axon regeneration during reperfusion via activating p38 MAPK signaling pathway. Ngb, mainly via its 7–122 aa fragment and oxygen-binding site H64, bound to and activated p38, which led to axon regeneration upon I/R.
Previous studies of Ngb have focused largely on neuronal death after I/R injury14,17. We discovered a novel function of Ngb under pathological conditions, i.e., inducing axon regrowth in ischemic brain. Ngb was selectively upregulated during 2–3 days of I/R (Fig. 1), in which initiating axon regeneration might be most favorable as acute cell injury/death process has passed while chronic glial proliferation/scar formation remains mild5. The accumulation of Ngb in growth cones of ischemic neurons including human ischemic brains strongly implies a functional link of Ngb to axon regeneration after I/R (Figs. 1 and 2). Further, we demonstrated causal effects of Ngb on inducing axon regeneration and expression of axon growth markers (e.g., GAP43 and Tau-1) during I/R. Therefore, we proposed that Ngb is an inducing factor for axon regeneration in the ischemic brain.
We demonstrated that Ngb promoted axon regeneration via activating p38 MAPK pathway. By using pharmacological inhibitors, we identified p38 as a major downstream target responsible for Ngb-induced axon regeneration during I/R although other kinases such as PI3K/Akt, extracellular signal–regulated kinase, c-Jun N-terminal kinase, and protein kinase C are also involved in axon outgrowth during development7,29,30,31,32,33. The requirement of p38 activation in Ngb-facilitated neurite regeneration was strengthened by the blocking effects of kinase-dead p38 (i.e., p38K53A). In PC12 cells, p38 MAPK is involved in nerve growth factor- and thermal-stimulated neurite outgrowth9,34, supporting a functional role of p38 MAPK pathway in axon/neurite regrowth under pathological conditions. We found that p-p38 was well co-localized with Ngb in ischemic neurons in the brain. Further, we demonstrated that Ngb overexpression enhanced p38 activation only upon I/R but not normoxia. Taken together, the evidence proves that Ngb–p38 signaling was selectively activated under ischemic reperfusion conditions, which further upregulated axon growth key proteins such as GAP43, Tau-1, and NF200 and finally induced axon regeneration.
We clarified the detailed mechanism of Ngb–p38 interactions during I/R. Ngb and p38 had a direct binding and this binding was increased upon reoxygenation (Fig. 4a). Serial truncation of Ngb peptide revealed that Ngb bound to p38 depending largely on the integrity of Ngb 7–122 fragment as further deletion of Ngb from both ends prominently reduced Ngb–p38 interactions (Fig. 4d). Deletion of Ngb 1–18 aa not only greatly reduced Ngb–p38 interactions but also abolished Ngb-induced p38 activation in neurons. Thus Ngb–p38 interaction was required for p38 activation during reperfusion. Ngb bound to not only p38 but also MKK3 in N2a cells upon OGD/Re (supplementary Figure S9). Since MKK3–p38 interactions are canonical for p38 activation34, an Ngb–p38–MKK3 complex may be formed and was involved in the regulation of p38 activation after I/R. Single mutation of Ngb at its oxygen-binding site (i.e., H64L) but not Gαi-binding sites (i.e., E53Q and E118Q) evidently increased Ngb–p38 binding upon OGD/Re or hypoxia, indicating that NgbH64L might lock Ngb in its oxygenated status20 and therefore enhance p38 binding. Consistent to its increased p38 binding, NgbH64L reinforced p38 activation and axon regeneration. Such evidence together support that Ngb promotes axon regeneration via coupling oxygen signal to p38 signaling in ischemic neurons during reperfusion.
Ischemic stroke causes severe neurite injury including axon retraction or breakdown. After 2 days of reperfusion, surviving neurons in penumbra area may recover from I/R injury and functional recovery may be initiated33,36,37,38,39. Ngb was upregulated during this period in response of reoxygenation or reperfusion. Ngb bound to O2 via H64 and H96 (located within Ngb 7–122 fragment), which may induce conformational change of Ngb15 and facilitate its protein–protein interactions20,22,23. The binding of Ngb to p38 may facilitate p38 phosphorylation and activation in the presence of MKK3, leading to upregulation of downstream target proteins including GAP43 and Tau-1 and finally promote axon regeneration in ischemic neurons during reperfusion.
In summary, our findings demonstrate that Ngb promotes axon/neurite regeneration after I/R via O2–Ngb–p38–MKK3–GAP43 signaling pathway (Fig. 6e). Since axon/neurite regeneration is indispensable for functional recovery of injured neurons in various neurological diseases including stroke, Ngb has potential therapeutic applications for axonopathy in neurological diseases as demonstrated by TAT-Ngb treatment in our study.
Materials and methods
Plasmids and antibodies
pEGFP-N1-Ngb wild-type (WT) and mutants (E53Q, E118Q, K119N, H64A, H64L, Y44D)19 and pGenesil-1-shNgb (short hairpin Ngb)20 were previously constructed. pEGFP-C1-Ngb WT and truncates (Δ1–6, Δ1–18, Δ1–35, Δ1–42, Δ106–151, Δ123–151, Δ128–151), pDEST26-CV-p38, and pDEST-Flag-NV-p38 were constructed in our laboratory. EST26-CV (C-terminal 137–238 Venus), pDEST26-CV-p38, pDEST-Flag-NV (N-terminal 1–157 Venus), pDEST-Flag-NV-p38, pDEST27-GST, and pDEST27-GST-p38 were kindly provided by Professor Haian Fu (Department of Pharmacology, School of Medicine, Emory University, USA). pDEST26-CV-Ngb and pDEST-Flag-NV-Ngb were previously constructed18. p-FU-p38K53A mutant plasmid was constructed by PCR amplifying p38K53A fragment (with stop codon) using specific primers and pDEST-Flag-NV-p38 template and then cloning into p-FU-Venus plasmids at BamH1/BsrG1sites. All plasmids were confirmed by sequencing before use. Antibodies against Ngb, Flag (Sigma, Saint Louis, MO, USA), GAP43, GFAP, NeuN, NF200, p-p38, p38 (Cell Signaling Technology, Boston, USA), β-tubulin, green fluorescent protein (GFP), Cygb, GST, His (Santa Cruz Biotechnology, Santa Cruz, USA), and Tau-1 (Merk Millipore Ltd., Darmstadt, Germany) were purchased.
Human brain tissues
Six paraffin-embedded human autopsy brain tissues were obtained from the Department of Pathology, Medical School of Yangtze University, three of which were from subjects with diagnosed cerebral infarction and had clear ischemic lesions while the other three from age-matched subjects without diagnosed neurological disorders had no clear ischemic lesions. The clinical information of brains is summarized in supplementary table 1.
tMCAo and ischemic reperfusion
C57BL/6J mice were purchased from Beijing Vital River Laboratory Animal Technology Company, LTD (Beijing, China). All animal experiments were performed in accordance with NIH guidelines and reviewed by the Ethics Committees of Huazhong University of Science and Technology. tMCAo was performed as previously described21,22. Briefly, adult mice (25–35 g) were anesthetized with 3% isoflurane (in 30% O2, 70% air) and maintained with 1.5% isoflurane. Rectal temperature was maintained at 37 ± 0.5 °C. After the right common carotid artery was isolated, the external branch of right common carotid artery was ligated. A silicone-coated monofilament nylon suture (0.22–0.23 mm in diameter) was gently introduced into the internal carotid artery through the external carotid artery stump, advancing to the anterior cerebral artery until a slight resistance was felt. Successful occlusion was verified by a Laser Doppler Flowmetry (moorVMS-LDF2, Axminster, UK). After 1 h of occlusion, the suture was withdrawn to allow reperfusion. Sham-operated mice underwent the same surgical procedure without suture insertion.
Western blotting analysis
Western blotting analysis was performed as previously described18,19,20,21,22. The blotted membranes were blocked with 5% nonfat dried milk and then incubated with primary antibodies. After incubation with corresponding IRDye 800 or IRDye 680 CW-conjugated goat anti-rabbit or anti-mouse immunoglobulin G (IgG) antibodies (LI-COR Biosciences, Lincoln, USA), the labeled bands were visualized and quantified by using an Odyssey Infrared Imaging System (LI-COR Biosciences).
IHC and immunofluorescent staining
IHC and immunofluorescent staining were performed as previously described18,19,20,21,22. Briefly, paraffin-embedded mouse or human brain tissues were blocked with 5% bovine serum albumin and then incubated with primary antibodies and corresponding secondary IgG/horseradish peroxidase polymer antibodies. Immunoreaction was visualized with diamino-benzidine tetrachloride. For immunofluorescent staining, the slices were incubated with corresponding Dylight 488/594-conjugated goat anti-rabbit or anti-mouse IgG antibodies (Abbkine, Redlands, USA) after primary antibody incubation. Negative controls were subjected to the same procedures with corresponding normal IgG. For statistical analysis, all micrographs were taken with the same parameters (nine micrographs/section) under a conventional microscope. The integral optical density (IOD) was estimated by using the software Image-Pro Plus 6.0 (Media Cybernetics Inc., Rockville, USA). Mean IOD was calculated as IOD sum/area.
Primary cultures of cerebral cortical neurons and lentiviral infection
Primary cultures of cerebral cortical neurons were prepared as previously described18,21,22. In brief, isolated cerebral cortical neurons from 16-day-old mouse embryos were cultured with neurobasal media supplemented with 2% B27 and 2 mM L-glutamine. Lentiviral infection was conducted in the neurons at 2 days in vitro (DIV) by supplementing concentrated lentivirus (LV) solution (Venus-Ngb-LV, Venus-LV, shNgb-GFP-LV, GFP-LV, 10% v/v) to culture media. The efficiency of lentiviral infection was over 90% as determined by GFP expression without evident cell death (see supplementary material, Figure S1). Cultured neurons were used at 7 DIV.
OGD and reoxygenation
OGD was performed as previously described20,22. Briefly, cultures were incubated with glucose-free Dulbecco’s modified Eagle’s medium media (Invitrogen, Grand Island, NY, USA) under 1%O2/95%N2/5%CO2 in a HealForce Tri Gas incubator (Heal Force Bio-meditech Holdings Limited, Shanghai, China). Following 1 h of OGD incubation, culture media were replaced with complete normal media and further incubated under normoxic conditions (reoxygenation, OGD/Re) for 24 h.
Axon/neurite measurement
Axon/neurite measurement was previously described18. The longest neurite length in each neuron or N2a cell was measured by using the software Image-Pro Plus 6.0, while the mean neurite length of 100 cells from three independent experiments was used for statistical analysis18.
N2a cultures and transfection
N2a cells were cultured as previously described18,20,22. Transient transfection with Neofect™ DNA transfection reagent (Neofect Biotech Co., Ltd, Beijing, China) was performed according to the manufacturer’s instructions and stable cell lines were established by neomycin selection. Fresh OPTI-MEM media (GIBCO BRL, USA) without serum was used to induce N2a cell differentiation18.
Bimolecular fluorescence complementation assay (BiFC)
BiFC were designed and carried out as previously described18. N2a cells were transiently co-transfected with pDEST26-CV/CV-Ngb+pDEST-Flag-NV/NV-p38 plasmids. Recombinant Venus fluorescent signal was photographed at 24 h of transfection. The relative fluorescence intensity from nine fields per culture was measured and the mean fluorescence intensity was used for statistical analysis. After photographing, cell lysates were extracted for western blotting analysis.
GST pull-down assay
GST pull-down assay was performed as previously described8,19,22. N2a cells were co-transfected with pDEST27-GST-p38+pEGFP-N1/C1-Ngb WT/mutants/truncates plasmids for 2 days. Total soluble proteins were incubated with glutathione sepharose beads (GE Healthcare Life Sciences, Piscataway, USA) overnight at 4 °C. After washing, the precipitates were collected and dissociate proteins from precipitates were subjected to western blotting analysis. Anti-GFP and anti-GST antibodies were used to probe corresponding fusion proteins.
Preparation of TAT-His-Ngb fusion proteins
Two oligonucleotides encoding a TAT protein transduction domain (TAT PTD, YGRKKRRQRRR, forward: 5′-CTAGCTATGGCCGTAAAAAACGTCGTCAGCGTCGTCGTG-3′, reverse: 5′-AATTCACGACGACGCTGACGACGTTTTTTACGGCCATAG-3′) was commercially synthesized, annealed, and inserted into pET28a in frame at Nhe I/EcoR I sites (i.e., pET28a-TAT). Human Ngb was inserted into pET28a/pET28a-TAT at EcoR1/Hind III sites (i.e., pET28a-Ngb and pET28a-TAT-Ngb). Expression of NGB and TAT-NGB in Escherichia coli BL21 (DE3) was induced by IPTG. The bacterial cells were harvested with binding buffer (500 mM NaCl, 20 mM Na3PO4, and 20 mM imidazole, pH 7.4) and disrupted by sonication. Following centrifugation, the supernatants were loaded onto a Ni-NTA resin column (GE Healthcare Life Sciences, Piscataway, NJ, USA). After washing with binding buffer, NGB peptides were eluted with elution buffer (500 mM NaCl, 20 mM Na3PO4, and 500 mM imidazole, pH 7.4) and refolded by using dialysis method. Protein concentration was measured by Bradford method. The purity and specificity of products were confirmed via sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis and western blot with anti-His monoclonal antibody correspondingly (supplementary Figure S2). NGB-His or TAT-NGB-His with a final concentration of 40 nM were supplemented to culture media during reoxygenation incubation.
Statistical analyses
All data were expressed as mean ± SEM of at least three independent experiments. For animal experiments, five to eight animals/group were randomly selected. Prism5 was used for statistical analysis, and unpaired Student’s test was used to compare between two groups. Pearson’s correlation was used for correlation study between two factors. Comparisons among multiple groups were performed through one-way analysis of variance with Fisher’s post hoc tests. P < 0.05 was considered to be significant.
References
Carmichael, S. T., Kathirvelu, B., Schweppe, C. A. & Nie, E. H. Molecular, cellular and functional events in axonal sprouting after stroke. Exp. Neurol. 287, 384–394 (2017).
Murphy, T. H. & Corbett, D. Plasticity during stroke recovery: from synapse to behaviour. Nat. Rev. Neurosci. 10, 861–872 (2009).
Hinman, J. D. The back and forth of axonal injury and repair after stroke. Curr. Opin. Neurol. 27, 615–623 (2014).
Sommer, C. J. & Schabitz, W. R. Fostering poststroke recovery: towards combination treatments. Stroke 48, 1112–1119 (2017).
Hemphill, M. A., Dauth, S., Yu, C. J., Dabiri, B. E. & Parker, K. K. Traumatic brain injury and the neuronal microenvironment: a potential role for neuropathological mechanotransduction. Neuron 85, 1177–1192 (2015).
Tobin, M. K. et al. Neurogenesis and inflammation after ischemic stroke: what is known and where we go from here. J. Cereb. Blood Flow Metab. 34, 1573–1584 (2014).
Filbin, M. T. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat. Rev. Neurosci. 4, 703–713 (2003).
O’Donovan, K. J. Intrinsic axonal growth and the drive for regeneration. Front Neurosci. 10, 486 (2016).
Jung, K. M. et al. Activation of p38 mitogen-activated protein kinase and activator protein-1 during the promotion of neurite extension of PC-12 cells by 15-deoxy-delta12,14-prostaglandin J2. Mol. Pharmacol. 63, 607–616 (2003).
Cui, Q. Actions of neurotrophic factors and their signaling pathways in neuronal survival and axonal regeneration. Mol. Neurobiol. 33, 155–179 (2006).
Jiang, J. J. et al. MicroRNA-26a supports mammalian axon regeneration in vivo by suppressing GSK3beta expression. Cell Death Dis. 6, e1865 (2015).
Sharma, T. P., Liu, Y., Wordinger, R. J., Pang, I. H. & Clark, A. F. Neuritin 1 promotes retinal ganglion cell survival and axonal regeneration following optic nerve crush. Cell Death Dis. 6, e1661 (2015).
Burmester, T., Weich, B., Reinhardt, S. & Hankeln, T. A vertebrate globin expressed in the brain. Nature 407, 520–523 (2000).
Baez, E. et al. Protection by neuroglobin expression in brain pathologies. Front Neurol. 7, 146 (2016).
Di Pietro, V. et al. Neuroglobin expression and oxidant/antioxidant balance after graded traumatic brain injury in the rat. Free Radic. Biol. Med. 69, 258–264 (2014).
Lan, W. B. et al. Overexpressing neuroglobin improves functional recovery by inhibiting neuronal apoptosis after spinal cord injury. Brain Res. 1562, 100–108 (2014).
Sun, F., Mao, X., Xie, L., Greenberg, D. A. & Jin, K. Neuroglobin protein is upregulated in Alzheimer’s disease. J. Alzheimers Dis. 36, 659–663 (2013).
Raida, Z., Hundahl, C. A., Kelsen, J., Nyengaard, J. R. & Hay-Schmidt, A. Reduced infarct size in neuroglobin-null mice after experimental stroke in vivo. Exp. Transl. Stroke Med. 4, 15 (2012).
Trent, J. T. 3rd, Watts, R. A. & Hargrove, M. S. Human neuroglobin, a hexacoordinate hemoglobin that reversibly binds oxygen. J. Biol. Chem. 276, 30106–30110 (2001).
Wakasugi, K., Nakano, T. & Morishima, I. Oxidized human neuroglobin acts as a heterotrimeric Galpha protein guanine nucleotide dissociation inhibitor. J. Biol. Chem. 278, 36505–36512 (2003).
Jayaraman, T. et al. 14-3-3 binding and phosphorylation of neuroglobin during hypoxia modulate six-to-five heme pocket coordination and rate of nitrite reduction to nitric oxide. J. Biol. Chem. 286, 42679–42689 (2011).
Li, L. et al. Neuroglobin promotes neurite outgrowth via differential binding to PTEN and Akt. Mol. Neurobiol. 49, 149–162 (2014).
Zhang, J., Lan, S. J., Liu, Q. R., Liu, J. M. & Chen, X. Q. Neuroglobin, a novel intracellular hexa-coordinated globin, functions as a tumor suppressor in hepatocellular carcinoma via Raf/MAPK/Erk. Mol. Pharmacol. 83, 1109–1119 (2013).
Pillai, V. B. et al. Acetylation of a conserved lysine residue in the ATP binding pocket of p38 augments its kinase activity during hypertrophy of cardiomyocytes. Mol. Cell. Biol. 31, 2349–2363 (2011).
Sun, Y. et al. Neuroglobin protects the brain from experimental stroke in vivo. Proc. Natl. Acad. Sci. USA 100, 3497–3500 (2003).
Qiu, X. Y. & Chen, X. Q. Neuroglobin - recent developments. Biomol. Concepts 5, 195–208 (2014).
Vallone, B., Nienhaus, K., Brunori, M. & Nienhaus, G. U. The structure of murine neuroglobin: novel pathways for ligand migration and binding. Proteins 56, 85–92 (2004).
Cai, J. et al. Mouse intermittent hypoxia mimicking apnoea of prematurity: effects on myelinogenesis and axonal maturation. J. Pathol. 226, 495–508 (2012).
Stankiewicz, T. R. & Linseman, D. A. Rho family GTPases: key players in neuronal development, neuronal survival, and neurodegeneration. Front. Cell Neurosci. 8, 314 (2014).
Fink, K. L., Lopez-Giraldez, F., Kim, I. J., Strittmatter, S. M. & Cafferty, W. B. J. Identification of intrinsic axon growth modulators for intact CNS neurons after injury. Cell Rep. 18, 2687–2701 (2017).
Baldauf, K. & Reymann, K. G. Influence of EGF/bFGF treatment on proliferation, early neurogenesis and infarct volume after transient focal ischemia. Brain Res. 1056, 158–167 (2005).
Lu, K. T. et al. Hippocampal neurogenesis after traumatic brain injury is mediated by vascular endothelial growth factor receptor-2 and the Raf/MEK/ERK cascade. J. Neurotrauma 28, 441–450 (2011).
Zhu, W. et al. Intranasal nerve growth factor enhances striatal neurogenesis in adult rats with focal cerebral ischemia. Drug Deliv. 18, 338–343 (2011).
Kudo, T. A. et al. Induction of neurite outgrowth in PC12 cells treated with temperature-controlled repeated thermal stimulation. PLoS ONE 10, e0124024 (2015).
Wang, Y. et al. SIRT1 increases YAP- and MKK3-dependent p38 phosphorylation in mouse liver and human hepatocellular carcinoma. Oncotarget 7, 11284–11298 (2016).
Chen, J. et al. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann. Neurol. 53, 743–751 (2003).
Jin, K. et al. Evidence for stroke-induced neurogenesis in the human brain. Proc. Natl. Acad. Sci. USA 103, 13198–13202 (2006).
Dempsey, R. J. & Kalluri, H. S. Ischemia-induced neurogenesis: role of growth factors. Neurosurg. Clin. N. Am. 18, 183–190 (2007). xi.
Kim, H. et al. Myeloperoxidase inhibition increases neurogenesis after ischemic stroke. J. Pharmacol. Exp. Ther. 359, 262–272 (2016).
Acknowledgements
This work was supported by the National Nature Science Foundation of China (No. 81471386 and No. 81672504 to XQC, No. 31571044 to BT); the Fundamental Research Funds for the Central Universities (No. 2017KFYXJJ048) to XQC; the Integrated Innovative Team for Major Human Diseases Program of Tongji Medical College, HUST; National Science Foundation of Hubei Province (No. 2017 CFB639) and Science and Technology Planning Project of Wuhan (No. 2017060201010202) to FP.
Author information
Authors and Affiliations
Contributions
In this study, X.X.X. performed the experiments, analyzed the data, and wrote the manuscript; R.Q.C. wrote the manuscript and provided editorial suggestions and criticism; D.X.H., X.Y.Q., C.Y.L., and X.Q.X. performed the experiments; B.T. provided editorial suggestions and criticism; F.P. and X.Q.C. conceived and designed the study, as well as wrote the manuscript. All the authors were involved in reviewing and commenting on the manuscript and gave their approval of the submitted version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Xiong, X., Pan, F., Chen, R. et al. Neuroglobin boosts axon regeneration during ischemic reperfusion via p38 binding and activation depending on oxygen signal. Cell Death Dis 9, 163 (2018). https://doi.org/10.1038/s41419-017-0260-8
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41419-017-0260-8
This article is cited by
-
Neuroglobin Facilitates Neuronal Oxygenation through Tropic Migration under Hypoxia or Anemia in Rat: How Does the Brain Breathe?
Neuroscience Bulletin (2023)
-
Macrophage-specific RhoA knockout delays Wallerian degeneration after peripheral nerve injury in mice
Journal of Neuroinflammation (2021)
-
Elevated Neuroglobin Lessens Neuroinflammation and Alleviates Neurobehavioral Deficits Induced by Acute Inhalation of Combustion Smoke in the Mouse
Neurochemical Research (2019)
-
Selective 14-3-3γ Upregulation Promotes Beclin-1-LC3-Autophagic Influx via β-Catenin Interaction in Starved Neurons In Vitro and In Vivo
Neurochemical Research (2019)